Hypersensitivity/Allergic Diseases Summer School
August 25-29, 2006
Aspen Meadows Resort, Aspen, Colorado
Presentations
| Saturday, August 26, 2006 | |
| 8:00 - 8:30 am | Erina Lin, MD Inflammatory Effects of Diesel Exhaust Particles in Children and Adults |
| 8:30 – 9:00 am | Vinay Mehta, MD |
| 9:00 – 9:30 am | David Naimi, DO Pilot Study: Adolescents and Asthma: The Perceived Risks and Benefits of Adherence |
| 9:30 – 10:00 am | Alkis Togias, MD How the Nose Speaks to the Lungs: Current Knowledge & Discussion of Future Work |
| 10:30 - 11:00 am | Eyal Oren, MD New Approaches to Diagnose Carboplatin Hypersensitivity |
| 11:00 - 11:30 am | Sean Lucas, MD Asthma and Breathlessness in School Age Children |
| 11:30 – 12:00 pm | Aleena Banerji, MD Evaluation of the Mechanism of ACE Inhibitor Angioedema |
| Noon – 12:30 pm | Rebecca Gruchalla, MD PhD Inner-City Anti-IgE Therapy for Asthma (ICATA) – Mechanistic Studies |
| 2:00 – 2:30 pm | Brian Vickery, MD Peanut Allergy Immunotherapy: The Development of a Modified Protein Vaccine |
| 2:30 – 3:00 pm | Adina Kay Knight, MD The CCR6-CCL20 Chemokine Axis is Necessary for Food Allergen-Induced Diarrhea |
| 3:00 – 3:30 pm | Wesley Burks, MD Peanut Allergy: Desensitization & Tolerance |
| 4:00 – 4:30 pm | Marie-Helene Sajous, MD |
| 4:30 – 5:00 pm | Sapandeep Singh, MD TSLP: The Master Switch for Atopy? |
| 5:00 - 5:30 pm | Stokes Peebles, MD Cyclooxygenase Regulation of Allergic Responses in the Lung |
Sunday, August 27, 2006 |
|
| 8:00 - 8:30 am | Hana Alachkar, MD T Regulatory Cell Activity as a Disease and a Prognostic Marker in Children with Eczema |
| 8:30 - 9:00 am | Kelly Stone, MD PhD Ganglioside-induced Toll-like Receptor Signaling Inhibition |
| 9:00 – 9:30 am | Zoulfia Allakhverdi, PhD Expression of CD103 Identifies Human Regulatory T cell Subsets |
| 9:30-10:00 am | Judith Woodfolk, MBChb PhD The Paradoxical Increase in CD25+ Tregs in Atopic Dermatitis Promotes a Th2 Response |
| 10:30 – 11:00 am | Diogenes Ferreira, MD Characterization of 73 Autopsy- proven Cases of Fatal Asthma in Sao Paulo, Brazil; Contractile and Synthetic Phenotype Gene Expression of Airway Smooth Muscle in Fatal Asthma |
| 11:00 – 11:30 am | Breck Nichols, MD Asthma Case Detection – The Breathmobile Program |
| 11:30 am – Noon | Melody Carter, MD Are Diagnostic Criteria for Mastocytosis Developed for Adults Applicable to Children? |
| Noon – 12:30 pm | James Gern, MD Urban Environment and Childhood Asthma |
Monday, August 28, 2006 |
|
| 8:00 - 8:30 am | Kathryn Hulse Analysis of the Immunomodulatory Effects of Targeting Cat Allergen to Antigen Presenting Cells |
| 8:30 - 9:00 am | David Sloane, MD Expression and Function of Leukocyte Immunoglobulin-like Receptors on Innate Immune Cells |
| 9:00 – 9:30 am | Sumita Roy-Ghanta, MD Future Directions for Wiskott-Aldrich Syndrome |
| 10:30 – 11:00 am | Oner Ozdemir, MD Omalizumab Trial in a Patient with Malignant Idiopathic Anaphylaxis |
| 11:00 – 11:30 am | Jody Tversky, MD Plasmacytoid Dendritic Cells in Allergy and Inflammation |
| 11:30 am – Noon | Elizabeth Erwin, MD Changes to the Immune Response to Cat Among University Students Undergoing Decreased Exposure to Cat Allergens |
| Noon – 12:30 pm | Lanny Rosenwasser, MD The Placebo Effect in Asthma |
| 1:30 – 2:00 pm | Nataliya Kushnir-Sukhov, MD 5-HT 1A Receptor Mediates Mast Cell Chemotaxis to Serotonin |
| 2:00 – 2:30 pm | Jin Ping Guo, MD PhD Targeting Siglec-8 and Siglec-F to Reduce Eosinophilic Responses in vitro and in vivo |
| 2:30 – 3:00 pm | Jianfeng Meng, MD CD23 and Its Genetic Polymorphisms in Allergic Reactions |
| 3:00 – 3:30 pm | Jonathan Arm, MD (Part 1 | Part 2) Regulation of Innate Immunity by a Secretory Phospholipase A2 |
| 3:30 – 4:00 pm | David Anmuth, MD Relationship of Asthma and BMI in Children Presenting to the Emergency Department with Acute Asthma |
| 4:00 – 4:30 pm | David Amrol, MD Specific IgE as a Predictor of Clinical Fire Ant Allergy |
| 4:30 – 5:00 pm | Thomas Platts-Mills, MD PhD Sensitization and Tolerance to Inhalant Allergens |